dc.creatorRamírez-Cheyne J.A.
dc.creatorDuque G.A.
dc.creatorAyala-Zapata S.
dc.creatorSaldarriaga-Gil W.
dc.creatorHagerman P.
dc.creatorHagerman R.
dc.creatorPayan-Gomez, Cesar
dc.date.accessioned2020-05-26T00:04:23Z
dc.date.accessioned2022-09-22T13:45:53Z
dc.date.available2020-05-26T00:04:23Z
dc.date.available2022-09-22T13:45:53Z
dc.date.created2020-05-26T00:04:23Z
dc.identifier00099163
dc.identifier13990004
dc.identifierhttps://repository.urosario.edu.co/handle/10336/23681
dc.identifierhttps://doi.org/10.1111/cge.13469
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3432228
dc.description.abstractFragile X syndrome (FXS) is the most common cause of inherited intellectual disabilities and autism spectrum disorders, and it is an X-linked disorder in which there is a deficiency of the fragile X mental retardation 1 protein. This protein is crucial in regulating translation of mRNAs related to dendritic maturation and cognitive development. The phenotype of FXS is characterized by neurobehavioral alterations, social deficits, communication difficulties, and findings which suggest an alteration of connective tissue, especially in the ligaments and muscles, cardiovascular system and genitourinary system. Connective tissue connects and supports all other tissues of the body and is composed of cells and extracellular matrix (ECM). Several proteins have been involved in the connective tissue abnormalities associated with the FXS, such as matrix metalloproteinase 9, which plays an important role in the homeostasis of the ECM, being a potential therapeutic target for certain tetracycline antibiotics that have shown beneficial effects in FXS. Here, we review connective tissue problems described in FXS. © 2018 John Wiley and Sons A/S. Published by John Wiley and Sons Ltd
dc.languageeng
dc.publisherBlackwell Publishing Ltd
dc.relationClinical Genetics, ISSN:00099163, 13990004, Vol.95, No.2 (2019); pp. 262-267
dc.relationhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85057324778&doi=10.1111%2fcge.13469&partnerID=40&md5=7115c5ba2438055d060d1b5a38a3bfab
dc.relation267
dc.relationNo. 2
dc.relation262
dc.relationClinical Genetics
dc.relationVol. 95
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.titleFragile X syndrome and connective tissue dysregulation
dc.typearticle


Este ítem pertenece a la siguiente institución